Interferon gamma inducible protein 10

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

IP-10 is Interferon gamma (INF-γ) inducible protein 10, and is also known as C-X-C Motif Chemokine Ligand 10 or CXCL10.[1] IP-10 is a chemokine, and important for recruiting natural killer cells to the myocardium, and for limiting viral duplication in murine (mice/rodent) coxsackievirus infection.[2]

Alternative names[edit | edit source]

IP-10 is also known as:

Function[edit | edit source]

ME/CFS[edit | edit source]

Notable studies[edit | edit source]

  • 2017 - The Role of IP-10 in Chronic Fatigue Syndrome[4]
This study found "compelling evidence" of the role of several cytokines/chemokines in the physiological and cognitive pathology in a group of patients with chronic fatigue syndrome, although these patients were selected using the Oxford criteria, which includes many patients with chronic fatigue not caused by ME/CFS.

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 1.2 "CXCL10 - C-X-C motif chemokine 10 precursor - Homo sapiens (Human) - CXCL10 gene & protein". uniprot.org. Retrieved January 24, 2019.
  2. 2.0 2.1 Loux, Tara J.; Lotze, Michael T.; Zeh, Herbert J. (January 1, 2010). Lotze, Michael T.; Thomson, Angus W. (eds.). Chapter Fourteen - NK cells as recipients of cytokine signals. San Diego: Academic Press. pp. 189–201. ISBN 9780123704542.
  3. Lee, James J.; Rosenberg, Helene F., eds. (January 1, 2013). Chapter 6 - Eosinophil Trafficking. Eosinophils in Health and Disease. Boston: Academic Press. pp. 121–166. ISBN 9780123943859.
  4. McArdle, Anne; Gusnanto, Arief; Earl, Kate; Sakellariou, George; Lawton, Clare; Owens, Daniel; Close, Graeme; Beadsworth, Michael; Dye, Louise (April 1, 2017). "The role of IP-10 in Chronic Fatigue Syndrome". The FASEB Journal. 1 (1 supplement): lb789. doi:10.1096/fasebj.31.1_supplement.lb789.